Quick Recap
Endocrine & Metabolic System, Protocol 3/9. Hypothyroidism/Myxedema Coma is covered as the companion protocol (4/9) with important shared principles (e.g., stress-dose steroids before thyroid hormone repletion).
1. Definition & Diagnosis
Severe hyperthyroidism with systemic decompensation, classically with fever and delirium ("thyroid storm") — a rare but life-threatening endpoint of the hyperthyroidism spectrum.
Diagnostic testing: plasma TSH, free T4, free T3. Clinical hyperthyroidism suppresses TSH below 0.1 mIU/L; a NORMAL plasma TSH is sufficient to EXCLUDE hyperthyroidism in nearly all cases. However, plasma TSH can ALSO be suppressed by severe nonthyroidal illness (rarely to undetectable) and by dopamine or high-dose glucocorticoid therapy — a suppressed TSH ALONE does NOT establish the diagnosis in a critically ill patient; confirm with an elevated free T4 or free T3 before committing to the diagnosis and treatment.
In critically ill patients, differential diagnosis of the underlying hyperthyroidism ETIOLOGY can be deferred — emergency treatment does not require first determining Graves' vs toxic nodular goiter vs thyroiditis; treat the storm, sort out etiology later.
2. Clinical Findings
Common (any hyperthyroidism): heat intolerance, weight loss, palpitations, sinus tachycardia, atrial fibrillation, brisk tendon reflexes, fine tremor, lid lag, proximal muscle weakness.
Seen primarily in SEVERE hyperthyroidism/storm: heart failure, exacerbation of coronary artery disease, fever and delirium.
Precipitating factors: cessation of antithyroid drugs, thyroidectomy, nonthyroidal surgery in unrecognized/undertreated hyperthyroidism, and acute intercurrent illness — actively screen for these triggers, particularly medication non-adherence and recent surgery.
3. Etiology (Informs Long-Term, Not Acute, Management)
Category | Causes |
Increased RAI uptake | Graves disease, toxic multinodular goiter, thyroid adenoma |
Decreased RAI uptake | Iodine-induced (amiodarone, iodinated contrast), painless thyroiditis, subacute thyroiditis, factitious hyperthyroidism |
Variable RAI uptake | Checkpoint inhibitors, lithium, interferon alpha, interleukin-2/other immunomodulatory drugs (these can also cause a transient thyrotoxicosis before later progressing to hypothyroidism) |
Amiodarone-induced hyperthyroidism is a specific, clinically important subtype — despite some advocacy for glucocorticoid-only treatment, the standard multi-agent emergency regimen (Section 4) has a HIGH SUCCESS RATE in this population and should not be abandoned in favor of steroid monotherapy.
4. Immediate Stabilization / Emergency Therapy — Full Regimen
Indicated when hyperthyroidism exacerbates heart failure or ACS, OR when thyroid storm is present — not for mild/uncomplicated hyperthyroidism.
Four simultaneous therapeutic targets:
- Rapid inhibition of thyroid hormone SYNTHESIS — thionamide (PTU or methimazole)
- Inhibition of thyroid hormone SECRETION — iodine (given AFTER the thionamide, Section 5 sequencing)
- Inhibition of the CARDIOVASCULAR effects — beta-adrenergic antagonist
- Inhibition of peripheral T4-to-T3 CONVERSION — hydrocortisone
Full dosing:
Agent | Dosing |
Propylthiouracil (PTU) | 500-1,000 mg PO LOAD, then 250 mg PO q6h |
Alternative: Methimazole | 60-80 mg PO daily in divided doses |
Iodine (SSKI) | Five drops (250 mg) PO q6h — START 1 HOUR AFTER the first thionamide dose |
Propranolol | 60-80 mg PO q6h |
Alternative: Esmolol | 500 mcg/kg IV bolus, then 50 mcg/kg/min IV infusion (preferred if IV access/titratability needed) |
Hydrocortisone | 100 mg IV q8h |
CRITICAL SEQUENCING RULE: iodine must be given AFTER (at least 1 hour after) the thionamide, never before or simultaneously — iodine given before thyroid synthesis is blocked can actually be USED AS SUBSTRATE for new thyroid hormone synthesis (Wolff-Chaikoff escape / Jod-Basedow-adjacent phenomenon), paradoxically worsening the thyrotoxicosis rather than controlling it. This is one of the most consequential sequencing rules in all of endocrine emergency medicine — getting the order backwards can make the patient worse.
Concurrent essential measures: aggressively treat fever and any concomitant precipitating illness — the storm will not resolve with thyroid-directed therapy alone if an untreated infection or other trigger persists.
Checklist:
5. Refractory Cases
Plasmapheresis/plasma exchange or emergency thyroidectomy can be considered for poor response to standard therapy — reserve for the rare patient not responding to the full standard regimen, involving endocrinology/surgery early once refractoriness is apparent.
6. Monitoring and Titration
Plasma free T4 should be measured every 3-7 days. As free T4 approaches the normal range, GRADUALLY decrease the doses of thionamide and iodine — do not abruptly stop either agent once improvement begins. Iodine can usually be stopped at the time of hospital discharge.
Definitive therapy (radioactive iodine or near-total thyroidectomy for Graves disease/toxic multinodular goiter) can be considered ONCE euthyroidism is achieved — this is a post-acute, outpatient-phase decision, not part of the emergency management. If long-term thionamide therapy is chosen instead of definitive therapy, methimazole is preferred for its once-daily dosing and reduced risk of major side effects (vs PTU, which is reserved acutely for its faster onset of action but carries more toxicity concerns for long-term use).
7. Cardiovascular Considerations
Cardiac findings are often prominent and can dominate the clinical picture: tachycardia, atrial fibrillation, heart failure, exacerbation of coronary artery disease (see Arrhythmias and Acute Coronary Syndrome protocols, Cardiovascular System, for management of these specific complications if they arise). Beta-blockade serves the dual purpose of symptomatic rate control AND (at high doses) modest additional inhibition of T4-to-T3 conversion.
8. Drug Toxicity Profile (Reference)
Drug | Rare toxicities | Common toxicities |
Propylthiouracil | Agranulocytosis, aplastic anemia, hepatotoxicity, lupus-like syndrome, hypoprothrombinemia, polymyositis | Rash, arthralgias, fever, leukopenia, nausea, vomiting |
Methimazole | (Similar class-related risks, generally lower toxicity burden than PTU) | — |
Propranolol | Heart block, bronchospasm, depression, nightmares, altered glucose metabolism, dyslipidemia, sexual dysfunction | Bradycardia, hypotension, fatigue, malaise, cold extremities |
SSKI (iodine) | Hypersensitivity reactions | Metallic taste, nausea, stomach upset, diarrhea, salivary gland swelling |
PTU's agranulocytosis and hepatotoxicity risk is a key reason methimazole is favored for longer-term/maintenance therapy once the acute storm has resolved.
9. Investigations
TSH, free T4, free T3; CBC (baseline before thionamide given agranulocytosis risk), LFTs (baseline given PTU hepatotoxicity risk), ECG/telemetry (arrhythmia surveillance), blood/urine/other cultures per precipitant workup, TSH-receptor antibodies or thyroid-stimulating immunoglobulin if Graves disease workup pursued (non-urgent, post-acute).
10. Organ Support
Beta-blockade for cardiovascular support; standard ICU supportive care for fever/hemodynamic instability; treat concurrent heart failure/arrhythmia per their dedicated protocols if present; aggressive treatment of the precipitating illness.
11. Consultation Matrix
Consultation | Trigger | Timing |
Endocrinology | All thyroid storm | Immediate |
Surgery | Emergency thyroidectomy consideration for refractory cases | If refractory to standard therapy |
Cardiology | Significant arrhythmia/heart failure complicating the storm | As needed |
12. Monitoring Framework
Continuous cardiac monitoring, serial free T4 (every 3-7 days once stabilizing), CBC trend (agranulocytosis surveillance on thionamide), LFT trend (hepatotoxicity surveillance), temperature (active fever management), fluid/hemodynamic status.
13. Complications
Heart failure/cardiovascular collapse, arrhythmia, agranulocytosis/hepatotoxicity from thionamide therapy, paradoxical worsening from incorrect iodine-before-thionamide sequencing, adrenal crisis if underlying autoimmune adrenal insufficiency coexists and is unmasked. Prevention: correct treatment sequencing, baseline CBC/LFT before thionamide, careful cardiovascular monitoring during beta-blockade. Rescue: plasmapheresis or emergency thyroidectomy for refractory storm, standard arrhythmia/heart failure rescue therapies.
14. Escalation & De-escalation
Escalate: poor response to standard 4-agent regimen -> plasmapheresis or emergency thyroidectomy, involve endocrinology/surgery.
De-escalate: free T4 trending toward normal -> gradually taper thionamide and iodine doses (never abrupt), stop iodine at discharge, transition to methimazole for long-term maintenance if definitive therapy (RAI/thyroidectomy) not immediately pursued.
15. ICU Discharge Criteria
Hemodynamically stable, fever resolved, free T4 trending toward normal, precipitating illness treated, thionamide/iodine doses appropriately tapered, definitive therapy (RAI vs thyroidectomy vs long-term thionamide) discussed with endocrinology.
16. Documentation & Medicolegal Checklist
17. Key Guidelines
Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343-1421.
18. Controversies
No clinical trials have rigorously determined the optimal specific regimen/dosing sequence for thyroid storm given its rarity — current practice is consensus/expert-opinion-based (reflected in the Washington Manual's own framing) rather than RCT-derived. Amiodarone-induced hyperthyroidism management (glucocorticoid-only vs the full standard regimen) has some genuine practice variation, though the full regimen is favored given its demonstrated high success rate. The precise threshold for escalating to plasmapheresis vs emergency thyroidectomy in refractory cases is not standardized and depends on institutional expertise/availability.
19. References
- Riek AE. Thyroid Disorders (Hyperthyroidism/Thyroid Storm section). Washington Manual of Critical Care, 4th ed, 2025 (Ch. 29).
- Endocrine Disorders drug dosing reference table. Washington Manual of Critical Care, 4th ed, 2025 (Ch. 95).
- Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343-1421.
- Burch HB, Wartofsky L. Life-threatening thyrotoxicosis: thyroid storm. Endocrinol Metab Clin North Am. 1993;22(2):263-277.
See also: Myxedema Coma (Endocrine & Metabolic System) for the companion hypothyroid emergency, including the shared "stress-dose steroids before hormone repletion" principle; Arrhythmias and Acute Coronary Syndrome (Cardiovascular System) for cardiovascular complication management.